There's more to young biopharma companies than their numbers, but those numbers are still an important part of each ...

Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through clinical trials. While the Bay Area biotech has yet to set ...

Spread the love“`html In an age where technology is advancing at breakneck speed, understanding the impact of modern ...

WASHINGTON - The Food and Drug Administration Wednesday granted supplemental approval for a breakthrough CRISPR gene therapy ...

Taika Waititi’s Sony Pictures adaptation of Ishiguro’s novel hits theaters October 23, 2026, and every technology the book imagined is real. Vision Transformers process images as Klara does — in ...

Japan's goal against Spain was a point of controversy during the 2022 World Cup Elsa/Getty Images New technology introductions at the 2026 World Cup mean officials will be able to check whether the ...

A team of engineers at the University of Florida has developed a new form of CRISPR technology that could make diagnostics and treatments safer, more precise, and more affordable, while opening the ...

A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while leaving healthy cells untouched. CRISPR-mediated gene editing technology has ...

The future of medicine is already here. Intellia Therapeutics, a leading biotechnology company, announced that its CRISPR-based treatment for a rare swelling condition has succeeded in a Phase 3 trial ...

Intellia Therapeutics Inc. said its gene-editing treatment for a rare swelling disorder met its goal in a late-stage trial, paving the way for the potential first approval of a new, simpler way of ...

Intellia Therapeutics said its Crispr-based treatment for a rare swelling condition succeeded in a Phase 3 trial, a landmark for gene editing. The treatment uses Nobel Prize-winning Crispr technology ...